2020
DOI: 10.1016/j.jinf.2020.01.007
|View full text |Cite
|
Sign up to set email alerts
|

Reduced susceptibility and resistance to bedaquiline in clinical M. tuberculosis isolates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
43
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(48 citation statements)
references
References 45 publications
3
43
0
Order By: Relevance
“…This is likely a function of the low frequency of viable spontaneous atpE mutants and their fitness costs observed in vivo (31). Although atpE mutations have been identified in a small number of BDQ-resistant clinical isolates to date (32, 33), Rv0678 mutations have been more prevalent. Therefore, overcoming Rv0678 -mediated resistance with more potent diarylquinolines like TBAJ-587 could greatly extend the utility and longevity of this important new class of drugs.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This is likely a function of the low frequency of viable spontaneous atpE mutants and their fitness costs observed in vivo (31). Although atpE mutations have been identified in a small number of BDQ-resistant clinical isolates to date (32, 33), Rv0678 mutations have been more prevalent. Therefore, overcoming Rv0678 -mediated resistance with more potent diarylquinolines like TBAJ-587 could greatly extend the utility and longevity of this important new class of drugs.…”
Section: Discussionmentioning
confidence: 99%
“…Although atpE mutations have been identified in a small number of BDQ-resistant clinical isolates to date(32,33), Rv0678 mutations have been more prevalent. Therefore, overcoming Rv0678-mediated resistance with more potent diarylquinolines like TBAJ-587 could greatly extend the utility and longevity of this important new class of drugs.Use of TBAJ-587 in place of BDQ in the BPaL regimen in mice infected with the Rv0678 mutant also largely prevented the selection of spontaneous PMD-resistant double mutants.Following two months of treatment, all five BPaL-treated mice harbored dual BDQ/PMDresistant isolates, compared with zero of ten SPaL-treated mice.…”
mentioning
confidence: 99%
“…2 ). Of those, insG in the HP nt192-198, which had been repeatedly demonstrated to confer BDQ and CFZ resistance during in vitro selection experiments and patient treatment, occurred in 82 isolates, whereas the other two double mutations were observed in only a single isolate, respectively (Andres et al, 2020; de Vos et al, 2019; Ghodousi et al, 2019; Peretokina et al, 2020; Sonnenkalb et al, 2021; Zhang et al, 2015). All of the former 82 double-LoF mutants belonged to a monophyletic group within sub-lineage 4.11 that was mostly multi-drug resistant (53 of 59 with known phenotypic data).…”
Section: Resultsmentioning
confidence: 99%
“…Many of the isolates with discordant pDST results had an MIC that was a single dilution above the breakpoint. It should also be noted that Rv0678 mutations have variable MICs, making a clear assessment of resistance determination challenging (11,26). Testing on an alternative phenotypic method, however, does seem to be a reasonable approach to confirm resistance at this stage when discordance is detected.…”
Section: Discussionmentioning
confidence: 99%